Matti Hero

2.2k total citations
63 papers, 1.4k citations indexed

About

Matti Hero is a scholar working on Reproductive Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Matti Hero has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Reproductive Medicine, 24 papers in Molecular Biology and 24 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Matti Hero's work include Hypothalamic control of reproductive hormones (23 papers), Sexual Differentiation and Disorders (17 papers) and Growth Hormone and Insulin-like Growth Factors (14 papers). Matti Hero is often cited by papers focused on Hypothalamic control of reproductive hormones (23 papers), Sexual Differentiation and Disorders (17 papers) and Growth Hormone and Insulin-like Growth Factors (14 papers). Matti Hero collaborates with scholars based in Finland, Denmark and United Kingdom. Matti Hero's co-authors include Leo Dunkel, Taneli Raivio, Päivi J. Miettinen, Sanna Wickman, Ensio Norjavaara, Tero Varimo, Sanna Toiviainen‐Salo, Outi Mäkitie, Kirsi Vaaralahti and Susan B. Nuñez and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Matti Hero

61 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matti Hero Finland 20 692 581 538 499 154 63 1.4k
Giovanna Municchi Italy 17 598 0.9× 511 0.9× 416 0.8× 288 0.6× 184 1.2× 32 1.1k
Fabio Buzi Italy 21 613 0.9× 283 0.5× 323 0.6× 316 0.6× 143 0.9× 57 1.5k
Ayfer Alikaşifoğlu Türkiye 20 502 0.7× 381 0.7× 240 0.4× 167 0.3× 119 0.8× 99 1.2k
Riccardo Selice Italy 27 593 0.9× 826 1.4× 664 1.2× 993 2.0× 137 0.9× 59 2.0k
Laura Audí Spain 22 412 0.6× 702 1.2× 533 1.0× 125 0.3× 117 0.8× 54 1.2k
Bessie E. Spiliotis Greece 17 948 1.4× 452 0.8× 368 0.7× 192 0.4× 310 2.0× 65 1.5k
Gönül Öçal Türkiye 18 483 0.7× 468 0.8× 397 0.7× 104 0.2× 158 1.0× 102 1.2k
Zeynep Şıklar Türkiye 20 432 0.6× 404 0.7× 389 0.7× 109 0.2× 163 1.1× 140 1.4k
Teoman Akçay Türkiye 19 383 0.6× 417 0.7× 315 0.6× 140 0.3× 77 0.5× 42 1.1k
F. De Luca Italy 25 924 1.3× 463 0.8× 382 0.7× 327 0.7× 259 1.7× 76 2.0k

Countries citing papers authored by Matti Hero

Since Specialization
Citations

This map shows the geographic impact of Matti Hero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Hero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Hero more than expected).

Fields of papers citing papers by Matti Hero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Hero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Hero. The network helps show where Matti Hero may publish in the future.

Co-authorship network of co-authors of Matti Hero

This figure shows the co-authorship network connecting the top 25 collaborators of Matti Hero. A scholar is included among the top collaborators of Matti Hero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Hero. Matti Hero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varimo, Tero, et al.. (2024). Central precocious puberty in boys: secular trend and clinical features. European Journal of Endocrinology. 190(3). 211–219. 4 indexed citations
2.
Hero, Matti, et al.. (2024). Utility of First-Morning-Voided Urinary Total Luteinizing Hormone in Detecting the Onset of Central Puberty. Hormone Research in Paediatrics. 99(1). 3–11.
3.
Hero, Matti, et al.. (2024). Prenatal, newborn and childhood factors and the timing of puberty in boys and girls. Pediatric Research. 96(3). 799–804. 1 indexed citations
4.
Hero, Matti, et al.. (2023). Sex‐independent timing of the onset of central puberty revealed by nocturnal luteinizing hormone concentrations. Clinical Endocrinology. 99(6). 552–558. 9 indexed citations
5.
Varimo, Tero, Päivi J. Miettinen, Kirsi Vaaralahti, et al.. (2022). Circulating Liver-enriched Antimicrobial Peptide-2 Decreases During Male Puberty. Journal of the Endocrine Society. 6(3). bvac013–bvac013. 5 indexed citations
6.
Pulkkinen, Mari‐Anne, Tero Varimo, Elina Hakonen, et al.. (2022). MiniMed 780G™ in 2- to 6-Year-Old Children: Safety and Clinical Outcomes After the First 12 Weeks. Diabetes Technology & Therapeutics. 25(2). 100–107. 36 indexed citations
7.
Hero, Matti, et al.. (2022). Quantification of urinary total luteinizing hormone immunoreactivity may improve the prediction of ovulation time. Frontiers in Endocrinology. 13. 903831–903831. 4 indexed citations
8.
Varimo, Tero, Hanna Huopio, Sirpa Tenhola, et al.. (2022). Health-related quality of life in boys with constitutional delay of growth and puberty. Frontiers in Endocrinology. 13. 1028828–1028828. 3 indexed citations
9.
Varimo, Tero, et al.. (2021). First year on commercial hybrid closed‐loop system—experience on 111 children and adolescents with type 1 diabetes. Pediatric Diabetes. 22(6). 909–915. 19 indexed citations
10.
Hero, Matti, Martti T. Tuomisto, Päivi J. Miettinen, et al.. (2021). Motivational Interviewing and Glycemic Control in Adolescents With Poorly Controlled Type 1 Diabetes: A Randomized Controlled Pilot Trial. Frontiers in Endocrinology. 12. 639507–639507. 2 indexed citations
11.
Irving, Melita, Matti Hero, Liisa M. Pelttari, et al.. (2021). Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia. Orphanet Journal of Rare Diseases. 16(1). 412–412. 9 indexed citations
12.
Hero, Matti, Tero Varimo, & Taneli Raivio. (2020). Aromatase inhibitors in puberty. Current Opinion in Endocrine and Metabolic Research. 14. 37–41. 6 indexed citations
13.
Hietamäki, Johanna, Louise Gregory, Kirsi Vaaralahti, et al.. (2020). Loss-of-Function Variants in TBC1D32 Underlie Syndromic Hypopituitarism. The Journal of Clinical Endocrinology & Metabolism. 105(6). 1748–1758. 18 indexed citations
14.
Varimo, Tero, Johanna Känsäkoski, Karoliina Wehkalampi, et al.. (2020). Familial central precocious puberty: two novel MKRN3 mutations. Pediatric Research. 90(2). 431–435. 7 indexed citations
15.
Korpela, Katri, Matti Hero, Päivi J. Miettinen, et al.. (2019). Intestinal Microbiota Development Differs Between Pubertal Boys and Girls. 92. 1 indexed citations
16.
Huopio, Hanna, Matti Hero, Päivi J. Miettinen, et al.. (2018). Recombinant Human FSH Treatment Outcomes in Five Boys With Severe Congenital Hypogonadotropic Hypogonadism. Journal of the Endocrine Society. 2(12). 1345–1356. 17 indexed citations
17.
Laitinen, Eeva‐Maria, Matti Hero, Kirsi Vaaralahti, Johanna Tommiska, & Taneli Raivio. (2012). Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism. International Journal of Andrology. 35(4). 534–540. 50 indexed citations
18.
Hero, Matti, Johanna Tommiska, Kirsi Vaaralahti, et al.. (2012). Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B. Fertility and Sterility. 97(5). 1242–1247. 37 indexed citations
19.
Hero, Matti, Anni Suomalainen, Jaana Hagström, et al.. (2012). Anti-tumor necrosis factor treatment in cherubism — Clinical, radiological and histological findings in two children. Bone. 52(1). 347–353. 38 indexed citations
20.
Wit, Jan M., Matti Hero, & Susan B. Nuñez. (2011). Aromatase inhibitors in pediatrics. Nature Reviews Endocrinology. 8(3). 135–147. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanna Municchi Breakdown of academic impact, for papers by Fabio Buzi Breakdown of academic impact, for papers by Ayfer Alikaşifoğlu Breakdown of academic impact, for papers by Riccardo Selice Breakdown of academic impact, for papers by Laura Audí Breakdown of academic impact, for papers by Bessie E. Spiliotis Breakdown of academic impact, for papers by Gönül Öçal Breakdown of academic impact, for papers by Zeynep Şıklar Breakdown of academic impact, for papers by Teoman Akçay Breakdown of academic impact, for papers by F. De Luca
Rankless by CCL
2026